Domestic PE firm Gaja Capital is reportedly considering a market debut while TA Associates has invested in health tech firm Vee Healthtek.
PE firm Gaja Capital eyes IPO
Domestic private equity (PE) firm Gaja Capital is weighing a public market debut, which will make it the first standalone investor in the country to explore the option, according to an ET report.
The mid-market-focused investment firm is understood to have roped in IIFL Capital to advise on the potential offering, the report further stated, quoting sources.
Preparations are already underway and Gaja could target to file its draft red herring prospectus as early as December.
Gaja Capital, founded by IIT Delhi alumnus Gopal Jain in 2004, invests in Indian mid-market companies and counts Amber, an accommodation platform for students; digital banking infrastructure enabler Signzy; and Leadsquared, a sales and marketing tech platform, among its portfolio.
TA Associates invests in Vee Healthtek
Global private equity (PE) firm TA Associates has announced the completion of a strategic growth investment in Vee Healthtek, which provides technology-enabled solutions and services for healthcare organisations.
The partnership will enable Vee Healthtek to leverage TA’s global resources and experience in the healthcare sector to enhance technology capabilities and expand its offerings, per a statement.
Vee Healthtek, which is a spinoff from the technology and IT services company Vee Technologies, is the healthcare-focused vertical of the 100-year-old The Sona Group with business interests in engineering, education, manufacturing, biotechnology, construction and plantations.
The investment marks TA Associates’s second deal in the Indian healthcare sector since 2022. Back then, it invested in biopharma-focused tech services company Zifo RnD Solutions.
